Disruptive Innovations US Speakers
Andreas Koester, MD, PhD
VP, Innovation, R&D Operations
As Head of Innovation, Research & Development Operations, Dr Andreas Koester is leading Janssen’s efforts to optimize the clinical trial process based on his 20+ years experience in pharmaceutical companies and CROs. (Contract Research Organizations).
Andreas is passionate about improving the way pharma runs clinical trials for the benefit of our 2 key partners: patients and investigators. Within J&J, he is leading efforts to develop capabilities and processes that streamline the clinical trial process and bring medical innovations to patients faster. Beyond Janssen, Andreas is active in the pre-competitive space, e.g. as contributor to Transcelerate Biopharma and co-creator of the Investigator Databank.
His background is in drug development, spanning first in human, proof of concept and large registration trials. He worked in leadership roles for trials that led to approvals of Prezista®, Intelence® and Reminyl®. Andreas is a graduate of Leipzig Medical School and earned his PhD in Clinical Pharmacology from Humboldt University in Berlin.